TY - JOUR
T1 - PIK3IP1 promotes extrafollicular class switching in T-Dependent immune responses
AU - Ottens, Kristina
AU - Schneider, Jalyn
AU - Kane, Lawrence P.
AU - Satterthwaite, Anne B.
N1 - Funding Information:
This work was supported by National Institues of Health/National Institute of Allergy and Infectious Diseases Grant AI126051. A.B.S. is a Southwestern Medical Foundation Scholar in Biomedical Research and holds the Peggy Chavellier Professorship in Arthritis Research and Treatment.
Publisher Copyright:
Copyright © 2020 by The American Association of Immunologists, Inc.
PY - 2020/10/15
Y1 - 2020/10/15
N2 - PI3K plays multiple roles throughout the life of a B cell. As such, its signaling is tightly regulated. The importance of this is illustrated by the fact that both loss- and gain-of-function mutations in PI3K can cause immunodeficiency in humans. PIK3IP1, also known as TrIP, is a transmembrane protein that has been shown to inhibit PI3K in T cells. Results from the ImmGen Consortium indicate that PIK3IP1 expression fluctuates throughout B cell development in a manner inversely correlated with PI3K activity; however, its role in B cells is poorly understood. In this study, we define the consequences of B cell–specific deletion of PIK3IP1. B cell development, basal Ig levels, and T-independent responses were unaffected by loss of PIK3IP1. However, there was a significant delay in the production of IgG during T-dependent responses, and secondary responses were impaired. This is likely due to a role for PIK3IP1 in the extrafollicular response because germinal center formation and affinity maturation were normal, and PIK3IP1 is not appreciably expressed in germinal center B cells. Consistent with a role early in the response, PIK3IP1 was downregulated at late time points after B cell activation, in a manner dependent on PI3K. Increased activation of the PI3K pathway was observed in PIK3IP1-deficient B cells in response to engagement of both the BCR and CD40 or strong cross-linking of CD40 alone. Taken together, these observations suggest that PIK3IP1 promotes extrafollicular responses by limiting PI3K signaling during initial interactions between B and T cells. The Journal of Immunology, 2020, 205: 2100–2108.
AB - PI3K plays multiple roles throughout the life of a B cell. As such, its signaling is tightly regulated. The importance of this is illustrated by the fact that both loss- and gain-of-function mutations in PI3K can cause immunodeficiency in humans. PIK3IP1, also known as TrIP, is a transmembrane protein that has been shown to inhibit PI3K in T cells. Results from the ImmGen Consortium indicate that PIK3IP1 expression fluctuates throughout B cell development in a manner inversely correlated with PI3K activity; however, its role in B cells is poorly understood. In this study, we define the consequences of B cell–specific deletion of PIK3IP1. B cell development, basal Ig levels, and T-independent responses were unaffected by loss of PIK3IP1. However, there was a significant delay in the production of IgG during T-dependent responses, and secondary responses were impaired. This is likely due to a role for PIK3IP1 in the extrafollicular response because germinal center formation and affinity maturation were normal, and PIK3IP1 is not appreciably expressed in germinal center B cells. Consistent with a role early in the response, PIK3IP1 was downregulated at late time points after B cell activation, in a manner dependent on PI3K. Increased activation of the PI3K pathway was observed in PIK3IP1-deficient B cells in response to engagement of both the BCR and CD40 or strong cross-linking of CD40 alone. Taken together, these observations suggest that PIK3IP1 promotes extrafollicular responses by limiting PI3K signaling during initial interactions between B and T cells. The Journal of Immunology, 2020, 205: 2100–2108.
UR - http://www.scopus.com/inward/record.url?scp=85092273047&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85092273047&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.2000584
DO - 10.4049/jimmunol.2000584
M3 - Article
C2 - 32887751
AN - SCOPUS:85092273047
SN - 0022-1767
VL - 205
SP - 2100
EP - 2108
JO - Journal of Immunology
JF - Journal of Immunology
IS - 8
ER -